SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-023080
Filing Date
2024-02-29
Accepted
2024-02-29 16:10:54
Documents
14
Period of Report
2024-02-29
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K xene-20240229.htm   iXBRL 8-K 48724
2 EX-99.1 xene-ex99_1.htm EX-99.1 176885
3 GRAPHIC img189401473_0.jpg GRAPHIC 6719
  Complete submission text file 0000950170-24-023080.txt   369624

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT xene-20240229.xsd EX-101.SCH 30840
15 EXTRACTED XBRL INSTANCE DOCUMENT xene-20240229_htm.xml XML 4688
Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Filer) CIK: 0001582313 (see all company filings)

IRS No.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36687 | Film No.: 24703702
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)